Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 26 citing Fuccio: Meta-analysis: duration of first-line proton-pump inhibitor-based triple therapy.... (0.24 sec) 

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori …

- annals.org [PDF] 
NS Jafri, CA Hornung, CW Howden - Annals of internal medicine, 2008 - Am Coll Physicians
Page 1. Meta-analysis: Sequential Therapy Appears Superior to Standard Therapy
for Helicobacter pylori Infection in Patients Naive to Treatment ...
Cited by 34 - Related articles - BL Direct - All 6 versions

Proton pump inhibitors: an update of their clinical use and pharmacokinetics


S Shi, U Klotz - European Journal of Clinical Pharmacology, 2008 - Springer
Abstract Background Proton pump inhibitors (PPIs) represent drugs of first
choice for treating peptic ulcer, Helicobacter pylori infection,
gastrooesophageal reflux disease, nonsteroidal anti-inflammatory drug ...
Cited by 23 - Related articles - All 2 versions

New concepts of resistance in the treatment of Helicobacter pylori infections


DY Graham, A Shiotani - Nature Clinical Practice Gastroenterology and …, 2008 - members.medscape.com
The prevalence of antimicrobial drug resistance is now so high that all patients
infected with Helicobacter pylori should be considered as having resistant
infections. Ideally, therapy should be based on pretreatment antibiotic- ...
Cited by 21 - Related articles - BL Direct - All 9 versions

[PDF] Gastric Cancer Consensus conference recommends Helicobacter pylori screening and …


NJ Talley, KM Fock, P Moayyedi - American Journal of Gastroenterology, 2008 - farncombe.mcmaster.ca
Gastric adenocarcinoma remains a common cause of death worldwide, and there is
convincing evidence that this cancer is causally linked to Helicobacter pylori.
The first Asian-Pacific Gastric Cancer Consensus brought together leading ...
Cited by 19 - Related articles - View as HTML - BL Direct - All 8 versions

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that …

- plosjournals.org
A Liberati, DG Altman, J Tetzlaff, C Mulrow, … - Journal of Clinical Epidemiology, 2009 - Elsevier
Since the development of the QUOROM (QUality Of Reporting Of Meta-analysis)
Statement—a reporting guideline published in 1999—there have been several
conceptual, methodological, and practical advances regarding the conduct ...
Cited by 11 - Related articles - All 33 versions

Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond

- adisonline.com [PDF] 
DY Graham, H Lu, Y Yamaoka - Drugs, 2008 - ingentaconnect.com
As with other bacterial infections, successful treatment of Helicobacter pylori
Abstract infections depends on the use of antibacterial agents to which the
organism is susceptible. In this article, we use the proposed report card ...
Cited by 10 - Related articles - BL Direct - All 6 versions

Helicobacter pylori eradication therapy: indications, efficacy and safety


A Kwok, T Lam, P Katelaris, RWL Leong - Expert Opin. Drug Saf., 2008 - informahealthcare.com
Background: Helicobacter pylori infects up to half of the world's population. It
remains the major cause of peptic ulcer disease and is recognised as a
carcinogen for its role in gastric carcinogenesis. Successful eradication ...
Cited by 9 - Related articles - BL Direct - All 6 versions

Sequential therapy for Helicobacter pylori: time to consider making the switch?


N Vakil, D Vaira - JAMA, 2008 - Am Med Assoc
A less frequently used regimen is quadruple therapy, consisting of bismuth plus
metronidazole, tetracycline, and a PPI administered for 10 days. It has been
suggested as an alternative to PPI triple therapy. The most recent US study ...
Cited by 7 - Related articles - All 2 versions

Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for …


A Villoria, P Garcia, X Calvet, JP Gisbert, M … - Alimentary Pharmacology and Therapeutics, 2008 - medscape.com
Acid inhibition is a key component of eradication therapy. The importance of
achieving adequate acid inhibition has been highlighted by recent studies.
Sugimoto et al. [10] analysed 24-h gastric pH during eradication therapy ...
Cited by 7 - Related articles - All 10 versions

[PDF] Helicobacter pylori eradication therapy success regarding different treatment period based …


F Kanizaj, M Katicic, B Skurla, M Ticak, V … - Helicobacter, 2009 - biblio.irb.hr
Blackwell Publishing Ltd Oxford, UK HELelicobacter 1083-4389 1523-5378 © 2008
The Authors Journal compilation © 2008 Blackwell Publishing Ltd, Helicobacter
XX: xx–xx XXX Original Article H. pylori Eradication Therapy Success ...
Cited by 3 - Related articles - View as HTML - All 10 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google